GFACX
Price
$61.91
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
JRANX
Price
$77.34
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

GFACX vs JRANX

Header iconGFACX vs JRANX Comparison
Open Charts GFACX vs JRANXBanner chart's image
American Funds Growth Fund of Amer C
Price$61.91
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Janus Henderson Research N
Price$77.34
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GFACX vs JRANX Comparison Chart
Loading...
VS
GFACX vs. JRANX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and JRANX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 284B vs. JRANX (23.3B). JRANX pays higher dividends than GFACX: JRANX (0.11) vs GFACX (0.00). GFACX was incepted earlier than JRANX: GFACX (24 years) vs JRANX (12 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. JRANX (27.00). GFACX has a lower initial minimum investment than JRANX: GFACX (250) vs JRANX (1000000). JRANX annual gain was more profitable for investors over the last year : 31.37 vs. GFACX (19.36). JRANX return over 5 years is better than : 64.34 vs. GFACX (41.61).
GFACXJRANXGFACX / JRANX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years12 years-
Gain YTD18.49124.96674%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets284B23.3B1,219%
Annual Yield % from dividends0.000.11-
Returns for 1 year19.3631.3762%
Returns for 3 years-7.0211.49-61%
Returns for 5 years41.6164.3465%
Returns for 10 years47.6879.4560%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VECO31.251.19
+3.96%
Veeco Instruments
OSK100.372.71
+2.77%
Oshkosh Corp
PRME4.090.04
+0.99%
Prime Medicine
ACRS1.180.01
+0.85%
Aclaris Therapeutics
UK1.44-0.01
-0.69%
Ucommune International Ltd